Advertisement
Canadian Journal of Cardiology

Recent Developments in Sex-Related Differences in Presentation, Prognosis, and Management of Coronary Artery Disease

  • Author Footnotes
    ∗ These authors contributed equally to this work.
    Mahraz Parvand
    Footnotes
    ∗ These authors contributed equally to this work.
    Affiliations
    Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
    Search for articles by this author
  • Author Footnotes
    ∗ These authors contributed equally to this work.
    Erin Rayner-Hartley
    Footnotes
    ∗ These authors contributed equally to this work.
    Affiliations
    Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
    Search for articles by this author
  • Tara Sedlak
    Correspondence
    Corresponding author: Dr Tara Sedlak, Division of Cardiology, Vancouver General Hospital, DHHC, 2775 Laurel St, Level 9, Vancouver, British Columbia V5Z 1M9, Canada. Tel.: +1-604-875-5487.
    Affiliations
    Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
    Search for articles by this author
  • Author Footnotes
    ∗ These authors contributed equally to this work.
Published:January 15, 2018DOI:https://doi.org/10.1016/j.cjca.2018.01.007

      Abstract

      Coronary artery disease (CAD) is the most prevalent type of heart disease among women and men. Sex-related differences in the presentation, prognosis, and management of patients with CAD has been increasingly studied. Compared with men, women are more likely to present with multiple comorbidities, have a higher prevalence of psychological risk factors, and present with atypical symptoms. These factors, along with delays in seeking medical attention, might contribute to sex-related treatment differences in women with stable angina and acute coronary syndrome. This review article highlights recent evidence examining sex-related differences in stable CAD patients with obstructive CAD, nonobstructive CAD, as well as myocardial infarction.

      Résumé

      La coronaropathie est le type de cardiopathie le plus courant chez les femmes et les hommes. De plus en plus d’études abordent les différences liées au sexe qui touchent le tableau clinique, le pronostic et la prise en charge de la coronaropathie. Comparativement aux hommes, les femmes sont plus susceptibles de présenter des maladies concomitantes multiples, une prévalence plus élevée des facteurs de risque psychologiques et des symptômes atypiques. Ces facteurs, conjugués avec le retard à demander des soins médicaux, pourraient contribuer à des différences de traitement liées au sexe chez les femmes présentant une angine stable et un syndrome coronarien aigu. Cet article de synthèse expose des données probantes récentes sur les différences liées au sexe dans les cas stables de coronaropathie obstructive, non obstructive ou concomitante à un infarctus du myocarde.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Smith Jr., S.C.
        • Collins A.
        • Ferrari R.
        • et al.
        Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke).
        J Am Coll Cardiol. 2012; 60: 2343-2348
        • Izadnegahdar M.
        • Mackay M.
        • Lee M.K.
        • et al.
        Sex and ethnic differences in outcomes of acute coronary syndrome and stable angina patients with obstructive coronary artery disease.
        Circ Cardiovasc Qual Outcomes. 2016; 9: S26-S35
        • Garcia M.
        • Mulvagh S.L.
        • Merz C.N.
        • Buring J.E.
        • Manson J.E.
        Cardiovascular disease in women: clinical perspectives.
        Circ Res. 2016; 118: 1273-1293
        • Wilmot K.A.
        • O'Flaherty M.
        • Capewell S.
        • Ford E.S.
        • Vaccarino V.
        Coronary heart disease mortality declines in the United States from 1979 through 2011: evidence for stagnation in young adults, especially women.
        Circulation. 2015; 132: 997-1002
        • Mosca L.
        • Benjamin E.J.
        • Berra K.
        • et al.
        Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the American Heart Association.
        J Am Coll Cardiol. 2011; 57: 1404-1423
        • Amsterdam E.A.
        • Wenger N.K.
        • Brindis R.G.
        • et al.
        2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        Circulation. 2014; 130: e344-e426
        • Bairey Merz C.N.
        • Pepine C.J.
        • Walsh M.N.
        • Fleg J.L.
        Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade.
        Circulation. 2017; 135: 1075-1092
        • Huxley R.R.
        • Woodward M.
        Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies.
        Lancet. 2011; 378: 1297-1305
        • Peters S.A.
        • Huxley R.R.
        • Woodward M.
        Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events.
        Diabetologia. 2014; 57: 1542-1551
        • Shah A.J.
        • Ghasemzadeh N.
        • Zaragoza-Macias E.
        • et al.
        Sex and age differences in the association of depression with obstructive coronary artery disease and adverse cardiovascular events.
        J Am Heart Assoc. 2014; 3: e000741
        • Ruane L.
        • H Greenslade J.
        • Parsonage W.
        • et al.
        Differences in presentation, management and outcomes in women and men presenting to an emergency department with possible cardiac chest pain.
        Heart Lung Circ. 2017; 26: 1282-1290
        • Canto J.G.
        • Rogers W.J.
        • Goldberg R.J.
        • et al.
        Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality.
        JAMA. 2012; 307: 813-822
        • Anand S.S.
        • Islam S.
        • Rosengren A.
        • et al.
        Risk factors for myocardial infarction in women and men: insights from the INTERHEART study.
        Eur Heart J. 2008; 29: 932-940
        • Ko D.T.
        • Wijeysundera H.C.
        • Udell J.A.
        • et al.
        Traditional cardiovascular risk factors and the presence of obstructive coronary artery disease in men and women.
        Can J Cardiol. 2014; 30: 820-826
        • Yusuf S.
        • Hawken S.
        • Ounpuu S.
        • et al.
        Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
        Lancet. 2004; 364: 937-952
        • Bushnell C.
        • McCullough L.D.
        • Awad I.A.
        • et al.
        Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2014; 45: 1545-1588
        • Puymirat E.
        • Simon T.
        • Steg P.G.
        • et al.
        Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction.
        JAMA. 2012; 308: 998-1006
        • Go A.S.
        • Mozaffarian D.
        • Roger V.L.
        • et al.
        Executive summary: heart disease and stroke statistics–2013 update: a report from the American Heart Association.
        Circulation. 2013; 127: 143-152
        • Huxley R.R.
        • Peters S.A.
        • Mishra G.D.
        • Woodward M.
        Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis.
        Lancet Diabetes Endocrinol. 2015; 3: 198-206
        • Steptoe A.
        • Kivimaki M.
        Stress and cardiovascular disease.
        Nat Rev Cardiol. 2012; 9: 360-370
        • Smolderen K.G.
        • Strait K.M.
        • Dreyer R.P.
        • et al.
        Depressive symptoms in younger women and men with acute myocardial infarction: insights from the VIRGO study.
        J Am Heart Assoc. 2015; 4: e001424
        • Albert P.R.
        Why is depression more prevalent in women?.
        J Psychiatry Neurosci. 2015; 40: 219-221
        • Cohen B.E.
        • Edmondson D.
        • Kronish I.M.
        State of the art review: depression, stress, anxiety, and cardiovascular disease.
        Am J Hypertens. 2015; 28: 1295-1302
        • Humphries K.H.
        • Izadnegahdar M.
        • Sedlak T.
        • et al.
        Sex differences in cardiovascular disease - impact on care and outcomes.
        Front Neuroendocrinol. 2017; 46: 46-70
        • Bosner S.
        • Haasenritter J.
        • Hani M.A.
        • et al.
        Gender bias revisited: new insights on the differential management of chest pain.
        BMC Fam Pract. 2011; 12: 45
        • Martin E.A.
        • Tan S.L.
        • MacBride L.R.
        • et al.
        Sex differences in vascular and endothelial responses to acute mental stress.
        Clin Auton Res. 2008; 18: 339-345
        • Oldehinkel A.J.
        • Bouma E.M.
        Sensitivity to the depressogenic effect of stress and HPA-axis reactivity in adolescence: a review of gender differences.
        Neurosci Biobehav Rev. 2011; 35: 1757-1770
        • Plu-Bureau G.
        • Hugon-Rodin J.
        • Maitrot-Mantelet L.
        • Canonico M.
        Hormonal contraceptives and arterial disease: an epidemiological update.
        Best Pract Res Clin Endocrinol Metab. 2013; 27: 35-45
        • Le-Ha C.
        • Beilin L.J.
        • Burrows S.
        • et al.
        Oral contraceptive use in girls and alcohol consumption in boys are associated with increased blood pressure in late adolescence.
        Eur J Prev Cardiol. 2013; 20: 947-955
        • Sokup A.
        • Goralczyk B.
        • Goralczyk K.
        • Rosc D.
        Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes.
        Acta Obstet Gynecol Scand. 2012; 91: 182-188
        • Fraser A.
        • Nelson S.M.
        • Macdonald-Wallis C.
        • et al.
        Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children.
        Circulation. 2012; 125: 1367-1380
        • Ahmed R.
        • Dunford J.
        • Mehran R.
        • Robson S.
        • Kunadian V.
        Pre-eclampsia and future cardiovascular risk among women: a review.
        J Am Coll Cardiol. 2014; 63: 1815-1822
        • Spracklen C.N.
        • Smith C.J.
        • Saftlas A.F.
        • Robinson J.G.
        • Ryckman K.K.
        Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis.
        Am J Epidemiol. 2014; 180: 346-358
        • Pelletier R.
        • Humphries K.H.
        • Shimony A.
        • et al.
        Sex-related differences in access to care among patients with premature acute coronary syndrome.
        CMAJ. 2014; 186: 497-504
        • Hemal K.
        • Pagidipati N.J.
        • Coles A.
        • et al.
        Sex differences in demographics, risk factors, presentation, and noninvasive testing in stable outpatients with suspected coronary artery disease: insights from the PROMISE trial.
        JACC Cardiovasc Imaging. 2016; 9: 337-346
        • Naoum C.
        • Berman D.S.
        • Ahmadi A.
        • et al.
        Predictive value of age- and sex-specific nomograms of global plaque burden on coronary computed tomography angiography for major cardiac events.
        Circ Cardiovasc Imaging. 2017; 10: e004896
        • Ford E.S.
        • Capewell S.
        Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates.
        J Am Coll Cardiol. 2007; 50: 2128-2132
        • Graham G.
        Acute coronary syndromes in women: recent treatment trends and outcomes.
        Clin Med Insights Cardiol. 2016; 10: 1-10
        • Singh J.A.
        • Lu X.
        • Ibrahim S.
        • Cram P.
        Trends in and disparities for acute myocardial infarction: an analysis of Medicare claims data from 1992 to 2010.
        BMC Med. 2014; 12: 190
        • Champney K.P.
        • Frederick P.D.
        • Bueno H.
        • et al.
        The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction.
        Heart. 2009; 95: 895-899
        • Berger J.S.
        • Elliott L.
        • Gallup D.
        • et al.
        Sex differences in mortality following acute coronary syndromes.
        JAMA. 2009; 302: 874-882
        • Bangalore S.
        • Fonarow G.C.
        • Peterson E.D.
        • et al.
        Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction.
        Am J Med. 2012; 125: 1000-1009
        • Zhang Z.
        • Fang J.
        • Gillespie C.
        • et al.
        Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction.
        Am J Cardiol. 2012; 109: 1097-1103
        • Pelletier R.
        • Choi J.
        • Winters N.
        • et al.
        Sex differences in clinical outcomes after premature acute coronary syndrome.
        Can J Cardiol. 2016; 32: 1447-1453
        • Schulman-Marcus J.
        • Hartaigh B.O.
        • Gransar H.
        • et al.
        Sex-specific associations between coronary artery plaque extent and risk of major adverse cardiovascular events: the CONFIRM long-term registry.
        JACC Cardiovasc Imaging. 2016; 9: 364-372
        • Sedlak T.L.
        • Lee M.
        • Izadnegahdar M.
        • et al.
        Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease.
        Am Heart J. 2013; 166: 38-44
        • Leipsic J.
        • Taylor C.M.
        • Gransar H.
        • et al.
        Sex-based prognostic implications of nonobstructive coronary artery disease: results from the international multicenter CONFIRM study.
        Radiology. 2014; 273: 393-400
        • Chaudhry S.I.
        • Khan R.F.
        • Chen J.
        • et al.
        National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999-2010.
        J Am Heart Assoc. 2014; 3: e001197
        • Sinnecker D.
        • Huster K.M.
        • Muller A.
        • et al.
        Sex differences in the non-invasive risk stratification and prognosis after myocardial infarction.
        J Electrocardiol. 2014; 47: 874-880
        • Henderson R.A.
        • O'Flynn N.
        Guideline Development Group. Management of stable angina: summary of NICE guidance.
        Heart. 2012; 98: 500-507
        • Chandrasekhar J.
        • Mehran R.
        Sex-based differences in acute coronary syndromes: insights from invasive and noninvasive coronary technologies.
        JACC Cardiovasc Imaging. 2016; 9: 451-464
        • Jespersen L.
        • Hvelplund A.
        • Abildstrom S.Z.
        • et al.
        Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events.
        Eur Heart J. 2012; 33: 734-744
        • Pauly D.F.
        • Johnson B.D.
        • Anderson R.D.
        • et al.
        In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).
        Am Heart J. 2011; 162: 678-684
        • Herrmann J.
        • Kaski J.C.
        • Lerman A.
        Coronary microvascular dysfunction in the clinical setting: from mystery to reality.
        Eur Heart J. 2012; 33: 2771-2782b
        • Pasupathy S.
        • Air T.
        • Dreyer R.P.
        • Tavella R.
        • Beltrame J.F.
        Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries.
        Circulation. 2015; 131: 861-870
        • Kaski J.C.
        • Rosano G.M.
        • Collins P.
        • et al.
        Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study.
        J Am Coll Cardiol. 1995; 25: 807-814
        • Antman E.M.
        • Cohen M.
        • Bernink P.J.
        • et al.
        The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making.
        JAMA. 2000; 284: 835-842
        • Granger C.B.
        • Goldberg R.J.
        • Dabbous O.
        • et al.
        Predictors of hospital mortality in the global registry of acute coronary events.
        Arch Intern Med. 2003; 163: 2345-2353
        • Boersma E.
        • Pieper K.S.
        • Steyerberg E.W.
        • et al.
        Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.
        Circulation. 2000; 101: 2557-2567
        • Allahwala U.K.
        • Tang J.
        • Murphy J.C.
        • Nelson G.I.
        • Bhindi R.
        Thrombolysis in myocardial infarction (TIMI) risk score and gender in the era of primary PCI–is there a difference?.
        Int J Cardiol. 2012; 161: 117-118
        • Gong I.Y.
        • Goodman S.G.
        • Brieger D.
        • et al.
        GRACE risk score: sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.
        Int J Cardiol. 2017; 244: 24-29
        • Sullivan A.L.
        • Beshansky J.R.
        • Ruthazer R.
        • et al.
        Factors associated with longer time to treatment for patients with suspected acute coronary syndromes: a cohort study.
        Circ Cardiovasc Qual Outcomes. 2014; 7: 86-94
        • Pagidipati N.J.
        • Peterson E.D.
        Acute coronary syndromes in women and men.
        Nat Rev Cardiol. 2016; 13: 471-480
        • Worrall-Carter L.
        • McEvedy S.
        • Wilson A.
        • Rahman M.A.
        Gender differences in presentation, coronary intervention, and outcomes of 28,985 acute coronary syndrome patients in Victoria, Australia.
        Womens Health Issues. 2016; 26: 14-20
        • Sarbaziha R.
        • Sedlak T.
        • Shufelt C.
        • Mehta P.K.
        • Merz C.N.
        Therapy for stable angina in women.
        P T. 2012; 37: 400-404
        • Tavris D.
        • Shoaibi A.
        • Chen A.Y.
        • et al.
        Gender differences in the treatment of non-ST-segment elevation myocardial infarction.
        Clin Cardiol. 2010; 33: 99-103
        • Mehta L.S.
        • Beckie T.M.
        • DeVon H.A.
        • et al.
        Acute myocardial infarction in women: a scientific statement from the American Heart Association.
        Circulation. 2016; 133: 916-947
        • Adatia F.
        • Galway S.
        • Grubisic M.
        • et al.
        Cardiac medication use in patients with acute myocardial infarction and nonobstructive coronary artery disease.
        J Womens Health (Larchmt). 2017; 26: 1185-1192
        • Montalescot G.
        • Sechtem U.
        • et al.
        • Task Force Members
        2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
        Eur Heart J. 2013; 34: 2949-3003
        • Galway S.
        • Adatia F.
        • Grubisic M.
        • et al.
        Sex differences in cardiac medication use post-catheterization in patients undergoing coronary angiography for stable angina with nonobstructive coronary artery disease.
        J Womens Health (Larchmt). 2017; 26: 976-983
        • Rayner-Hartley E.
        • Sedlak T.
        Ranolazine: a contemporary review.
        J Am Heart Assoc. 2016; 5: e003196
        • Bairey Merz C.N.
        • Handberg E.M.
        • Shufelt C.L.
        • et al.
        A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.
        Eur Heart J. 2016; 37: 1504-1513
        • O'Gara P.T.
        • et al.
        • American College of Emergency Physicians
        • Society for Cardiovascular Angiography and Interventions
        2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2013; 61: e78-e140
        • Ibanez B.
        • James S.
        • Agewall S.
        • et al.
        2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
        Eur Heart J. 2018; 39: 119-177
        • Tamis-Holland J.E.
        • Palazzo A.
        • Stebbins A.L.
        • et al.
        Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy.
        Am Heart J. 2004; 147: 133-139
        • Amsterdam E.A.
        • Wenger N.K.
        • Brindis R.G.
        • et al.
        2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        Circulation. 2014; 130: 2354-2394
        • O'Donoghue M.
        • Boden W.E.
        • Braunwald E.
        • et al.
        Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis.
        JAMA. 2008; 300: 71-80
        • Glaser R.
        • Herrmann H.C.
        • Murphy S.A.
        • et al.
        Benefit of an early invasive management strategy in women with acute coronary syndromes.
        JAMA. 2002; 288: 3124-3129
        • Lagerqvist B.
        • Safstrom K.
        • Stahle E.
        • et al.
        Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators.
        J Am Coll Cardiol. 2001; 38: 41-48
        • Clayton T.C.
        • Pocock S.J.
        • Henderson R.A.
        • et al.
        Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial.
        Eur Heart J. 2004; 25: 1641-1650
        • Poon S.
        • Goodman S.G.
        • Yan R.T.
        • et al.
        Bridging the gender gap: insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes.
        Am Heart J. 2012; 163: 66-73
        • Kumbhani D.J.
        • Fonarow G.C.
        • Cannon C.P.
        • et al.
        Predictors of adherence to performance measures in patients with acute myocardial infarction.
        Am J Med. 2013; 126: 74.e1-74.e9
        • Gukathasan N.
        • Witzenbichler B.
        • Weisz G.
        • et al.
        Impact of gender on patterns of dual antiplatelet therapy cessation and non-adherence: one-year results from the Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients (PARIS), an observational single-arm study.
        J Am Coll Cardiol. 2013; 61: E1531
        • Baigent C.
        • Blackwell L.
        • et al.
        • Antithrombotic Trialists' (ATT) Collaboration
        Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
        Lancet. 2009; 373: 1849-1860
        • Berger J.S.
        • Bhatt D.L.
        • Cannon C.P.
        • et al.
        The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis.
        J Am Coll Cardiol. 2009; 54: 1935-1945
        • Dewilde W.J.
        • Oirbans T.
        • Verheugt F.W.
        • et al.
        Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.
        Lancet. 2013; 381: 1107-1115
        • Gibson C.M.
        • Mehran R.
        • Bode C.
        • et al.
        Prevention of bleeding in patients with atrial fibrillation undergoing PCI.
        N Engl J Med. 2016; 375: 2423-2434
        • Cannon C.P.
        • Bhatt D.L.
        • Oldgren J.
        • et al.
        Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation.
        N Engl J Med. 2017; 377: 1513-1524
        • Patti G.
        • De Caterina R.
        • Abbate R.
        • et al.
        Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A ‘state-of-the-art’ paper.
        Eur Heart J. 2014; 35: 2213-2223b
        • Yusuf S.
        • Peto R.
        • Lewis J.
        • Collins R.
        • Sleight P.
        Beta blockade during and after myocardial infarction: an overview of the randomized trials.
        Prog Cardiovasc Dis. 1985; 27: 335-371
        • Bangalore S.
        • Makani H.
        • Radford M.
        • et al.
        Clinical outcomes with beta-blockers for myocardial infarction: a meta-analysis of randomized trials.
        Am J Med. 2014; 127: 939-953
        • Pfeffer M.A.
        • McMurray J.J.
        • Velazquez E.J.
        • et al.
        Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
        N Engl J Med. 2003; 349: 1893-1906
        • Flather M.D.
        • Yusuf S.
        • Kober L.
        • et al.
        Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.
        Lancet. 2000; 355: 1575-1581
        • Garg R.
        • Yusuf S.
        Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.
        JAMA. 1995; 273: 1450-1456
      1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
        Lancet. 1994; 344: 1383-1389
        • Gutierrez J.
        • Ramirez G.
        • Rundek T.
        • Sacco R.L.
        Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis.
        Arch Intern Med. 2012; 172: 909-919
        • Hsue P.Y.
        • Bittner V.A.
        • Betteridge J.
        • et al.
        Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials.
        Am J Cardiol. 2015; 115: 447-453
        • Eikelboom J.W.
        • Connolly S.J.
        • Bosch J.
        • et al.
        Rivaroxaban with or without aspirin in stable cardiovascular disease.
        N Engl J Med. 2017; 377: 1319-1330
        • Moscucci M.
        • Fox K.A.
        • Cannon C.P.
        • et al.
        Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).
        Eur Heart J. 2003; 24: 1815-1823
        • de Andrade P.B.
        • Tebet M.A.
        • Maia da Silva F.S.
        • et al.
        Major bleeding in acute coronary syndromes.
        J Invasive Cardiol. 2011; 23: 485-490
        • Johnston N.
        • Schenck-Gustafsson K.
        • Lagerqvist B.
        Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain?.
        Eur Heart J. 2011; 32: 1331-1336
        • Mieres J.H.
        • Gulati M.
        • Bairey Merz N.
        • et al.
        Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association.
        Circulation. 2014; 130: 350-379
        • Mehta R.H.
        • Stebbins A.S.
        • Lopes R.D.
        • et al.
        Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis.
        Am J Cardiol. 2012; 109: 320-326
        • Villano A.
        • Di Franco A.
        • Nerla R.
        • et al.
        Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.
        Am J Cardiol. 2013; 112: 8-13